Abstract
The authors note a considerable discrepancy in the frequency of adverse reactions reported after bronchography with Hytrast as used in America to the excellent tolerance reported in Europe and South Africa. The Hytrast used in America has a different formulation to that used in Europe: it is much less viscous and causes more ‘alveolarisation’. Experimental bronchography in dogs did not however reveal any difference in inflammatory response whether the contrast medium was Hytrast (French), Hytrast (as used in America) and Dionosil oily. The different methods of handling of contrast medium in the lung are discussed. The authors recommend that Hytrast (French) should not be modified before bronchography.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
